Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Personalized medicine, also termed Theranostics or precision medicine, is a medical procedure that separates patients into different groups—with medical decisions, practices, interventions and/or products being tailored to the individual patient based on their predicted response or risk of disease.[1] The terms personalized medicine, precision medicine, stratified medicine and P4 medicine are used interchangeably to describe this concept[1][2] though some authors and organisations use these expressions separately to indicate particular nuances.
The Personalized Medicine market revenue was xx Million USD in 2016, grew to xx Million USD in 2021, and will reach xx Million USD in 2026, with a CAGR of xx during 2021-2026.
Considering the influence of COVID-19 on the global Personalized Medicine market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.
This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.
Under COVID-19 Outbreak, how the Personalized Medicine Industry will develop is also analyzed in detail in Chapter 1.8 of this report.
Major Players in Personalized Medicine market are:
Biogen, Inc
Exagen Diagnostics, Inc.
Genelex Corporation
QIAGEN
Precision Biologics, Inc
Asuragen, Inc.
Decode Genetics, Inc.
Celera Diagnostics LLC
Dako A/S
Danaher Corporation (Cepheid, Inc.)
Exact Science Corporation
GE Healthcare
Illumina, Inc.
Abbott Laboratories
Most important types of Personalized Medicine products covered in this report are:
PM Diagnostics
PM Therapeutics
Personalized Medical Care
Personalized Nutrition & Wellness
Most widely used downstream fields of Personalized Medicine market covered in this report are:
Diagnostic Companies
Pharmaceutical Companies
Healthcare Companies
Others
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others
In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.
In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.
In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.
2020
The Personalized Medicine market revenue was xx Million USD in 2016, grew to xx Million USD in 2021, and will reach xx Million USD in 2026, with a CAGR of xx during 2021-2026.
Considering the influence of COVID-19 on the global Personalized Medicine market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.
This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.
Under COVID-19 Outbreak, how the Personalized Medicine Industry will develop is also analyzed in detail in Chapter 1.8 of this report.
Major Players in Personalized Medicine market are:
Biogen, Inc
Exagen Diagnostics, Inc.
Genelex Corporation
QIAGEN
Precision Biologics, Inc
Asuragen, Inc.
Decode Genetics, Inc.
Celera Diagnostics LLC
Dako A/S
Danaher Corporation (Cepheid, Inc.)
Exact Science Corporation
GE Healthcare
Illumina, Inc.
Abbott Laboratories
Most important types of Personalized Medicine products covered in this report are:
PM Diagnostics
PM Therapeutics
Personalized Medical Care
Personalized Nutrition & Wellness
Most widely used downstream fields of Personalized Medicine market covered in this report are:
Diagnostic Companies
Pharmaceutical Companies
Healthcare Companies
Others
Major Region
s or countries covered in this report:North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others
In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.
In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.
In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.
Years considered for this report:
Historical Years:
2016-2020Base Year:
2020Estimated Year:
2021Forecast Period:
2021-2026Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
